Search the Newsreel

Crescent Biopharma (NASDAQ:CBIO) Issues Earnings Results, Misses Estimates By $0.04 EPS

Crescent Biopharma (Nasdaq: CBIO) posts Q2 loss, extends cash runway to 2028

Silvercrest (SAMG) Q2 Earnings and Revenues Miss Estimates

Cresud SACIF y A (CRESY) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Cresud SACIF y A (CRESY), highlighting its current risk score of 4.31, which ranks it 55 out of 93 in the Food & Tobacco industry. The assessment notes the company's beta of 0.75, indicating lower volatility than …

FutureCrest Acquisition Ord Shs Class A (FCRS) Income Statement

This article provides an overview of FutureCrest Acquisition Ord Shs Class A (FCRS) income statement on TradingKey. It explains how to interpret the financial data, clarifies the difference between quarterly and annual statements, and defines key metrics like YOY and EPS. The company's income …

Crescent Energy, Northern Oil and Gas, HighPeak Energy, Occidental Petroleum, and Matador Resources Shares Skyrocket, What You Need To Know

What Happened? A number of stocks jumped in the afternoon session after renewed fighting across the Middle East, and a larger-than-expected drop in U.S. crude stockpiles reinforced concerns over oil supply. Crude oil futures jumped more than 6%—snapping a three-day losing streak—as renewed fighting …

ACRES Commercial: Q2 Earnings Snapshot

Cresud SA Sponsored ADR Revenue Breakdown – LSX:906164

The article provides a revenue breakdown for Cresud SA Sponsored ADR (LSX:906164), highlighting that the greatest contribution to its revenue came from Argentina. In the last fiscal year, Argentina accounted for €500.40 million, down from €734.02 million the previous year. This indicates a significant …

Crescent Biopharma (Nasdaq:CBIO) - Stock Analysis

Crescent Biopharma (Nasdaq:CBIO) is a biotechnology company focused on developing cancer therapies. The company, with a market cap of US$610.4m, recently completed a follow-on equity offering and is advancing its pipeline candidates CR-001 (a PD-1 x VEGF bispecific antibody) and CR-003 (an ITGB6-targeted ADC) …

Cresud SA Revenue Breakdown – BCBA:CRES

This article provides a revenue breakdown for Cresud SA (BCBA:CRES), highlighting that the greatest contribution to its revenue comes from Argentina. In the last year, Argentina accounted for 610.37 billion ARS, an increase from 484.96 billion ARS in the previous year. The data includes …

Crescent Energy to Report Q2 Earnings: What's in Store?

Crescent Energy Company CRGY is set to release second-quarter 2026 results on Aug. 3. The Zacks Consensus Estimate for the to-be-reported quarter is pegged at a profit of 59 cents per share on revenues of $1.2 billion. Let's delve into the factors that might …

Cresud SACIF y A (CRESY) Institutional Confidence

The article analyzes the institutional confidence in Cresud SACIF y A (CRESY), showing its institutional shareholding score as 3.00, placing it 55th out of 93 in the Food & Tobacco industry. The institutional shareholding proportion is 21.72%, a 5.14% decrease quarter-over-quarter. It also lists …

The Technical Signals Behind (CRESY) That Institutions Follow

This article from Stock Traders Daily discusses the technical signals for Cresud S.a.c.i.f. Y A. (NASDAQ: CRESY), highlighting strong sentiment across all horizons and an overweight bias. It outlines three AI-generated institutional trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—with specific entry zones, targets, …

Crest Ventures issues 44th AGM notice, reminds shareholders to update contact details

ACRES Commercial Realty (NYSE:ACR) Posts Quarterly Earnings Results, Misses Expectations By $2.44 EPS

ACRES Commercial Realty (ACR): Eagle Point accounts sell 3,807 Series D preferred shares

Insider Selling: ACRES Commercial Realty (NYSE:ACR) Major Shareholder Sells 1,389 Shares of Stock

ACRES Commercial Realty (NYSE: ACR) reports Q2 loss and advances manager internalization

Acres Commercial Realty earnings missed by $0.92, revenue topped estimates

Crest Nicholson Holdings plc (LON:CRST) Given Consensus Rating of "Hold" by Analysts

CBIO|Crescent Biopharma Ord Shs|Price:16.510|Chg%:-0.420

This article provides a detailed financial overview of Crescent Biopharma Ord Shs (CBIO), including its current stock price, market capitalization, key figures, and historical performance. It also features analyst ratings, indicating a "Buy" consensus with a target price of $31.00, and lists major shareholders. …

Exome Asset Management LLC Makes New $2.81 Million Investment in Crescent Biopharma, Inc. $CBIO

Cresud SACIF y A (CRESY) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

Crescent Capital BDC Inc (CCAP) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for Crescent Capital BDC Inc (CCAP), noting its current valuation score of 7.44 and its ranking within the Collective Investments industry. It details the company's current P/E ratio, comparing it to recent highs and lows, and indicates that …

Silvercrest Asset Management Group to Host Second Quarter 2026 Earnings Conference Call

Silvercrest Asset Management Group Inc. announced it will host a teleconference on July 31, 2026, at 8:30 am Eastern Time to discuss its second quarter 2026 financial results. Chairman and CEO Richard R. Hough III and CFO Scott A. Gerard will lead the call, …

Crescent Energy (CRGY) major holder BlackRock discloses 11.2% ownership stake

BlackRock, Inc. has disclosed an 11.2% ownership stake in Crescent Energy Co (CRGY) Class A stock, according to an amended Schedule 13G filing. This amounts to 37,098,664 shares beneficially owned by BlackRock's various business units. BlackRock holds sole voting power over 36,758,431 shares and …

Crescent Biopharma Market Sentiment

This article provides a market sentiment analysis for Crescent Biopharma (CBIO), detailing analyst consensus, short interest, options flow, and insider activity. Key signals show a "Buy" analyst consensus, a rising short interest of 30.4%, bullish options flow with a 0.50 Put/Call ratio, and net …

Crescent Energy Co (CRGY) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

FutureCrest Acquisition Ord Shs Class A (FCRS) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of FutureCrest Acquisition Ord Shs Class A (FCRS), identifying major shareholders and institutional holdings. It lists the top five shareholders by proportion, including MMCAP Asset Management and Governors Lane LP, and categorizes shareholders by type such as hedge …

CCAP|Crescent Capital BDC Inc|Price:11.325|

Crescent Energy (CRGY) to Announce Quarterly Earnings on Monday

Crescent Energy (CRGY) Reports Next Week: Wall Street Expects Earnings Growth

Investors and public can hear Silvercrest's July 31 results call

FutureCrest Acquisition Ord Shs Class A (FCRS) Valuation: PE, PB & Fair Value Analysis

This article provides a brief overview of FutureCrest Acquisition Ord Shs Class A (FCRS), including its market data and a general statement about valuation analysis (PE, PB, Fair Value). It lists the current stock price, market cap, and indicates that the P/E TTM is …

CCAP|Crescent Capital BDC Inc|Price:10.840|Chg%:+0.060

Crescent Capital BDC Inc. (CCAP) specializes in lending to middle-market companies, aiming to maximize stockholder returns through debt and equity investments. The company focuses on secured and unsecured debt, as well as related equity securities, primarily engaging in private credit transactions and syndicated loans. …

Silvercrest Asset Management to report Q2 2026 results and hold investor call on July 31

Silvercrest Asset Management Group Inc. is scheduled to announce its second-quarter financial results for the period ending June 30, 2026, on July 31, 2026. The company will host a teleconference at 8:30 am Eastern Time on the same day to discuss the results and …